Bath & Body Works stock price target lowered to $28.50 at Jefferies

Published 13/10/2025, 21:44
Bath & Body Works stock price target lowered to $28.50 at Jefferies

Investing.com - Jefferies has reduced its price target on Bath & Body Works Inc. (NYSE:BBWI) to $28.50 from $32.00 while maintaining a Hold rating on the stock.

The firm’s analysis indicates Bath & Body Works has made limited progress in reducing promotional activity both online and in physical stores, with new product launches quickly moving to discount pricing despite the CEO’s stated strategy to decrease reliance on sales promotions.

Jefferies noted the company’s recent Disney Villains collection launch underperformed compared to the previous Disney Princess collaboration, raising questions about the retailer’s ability to drive sustainable momentum through product innovation rather than discounting.

The research firm’s checks revealed both foot traffic in stores and web traffic showed limited improvement from new product introductions, suggesting innovation alone has not significantly boosted customer engagement.

Given the persistent promotional environment, uneven impact of product launches, and broader economic uncertainty, Jefferies sees limited near-term upside potential for Bath & Body Works’ sales and profit margins.

In other recent news, The Brand House Collective, Inc. reported second-quarter results that did not meet analyst expectations. The company’s revenue decreased by nearly 12% compared to the same period last year. This decline comes as The Brand House Collective is undergoing a transition period marked by the opening of its first Bed Bath & Beyond Home store and recent intellectual property transactions. Despite these developments, the company’s stock showed a slight increase in pre-market trading. Investors are closely watching how these strategic moves will impact future performance. The revenue shortfall highlights the challenges faced during this transition phase. Analyst opinions on the company’s future remain varied, with some firms monitoring the situation closely.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.